跳至主要内容
临床试验/NCT02881931
NCT02881931已完成不适用

FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease

CHDI Foundation, Inc.4 个研究点 分布在 2 个国家目标入组 75 人开始时间: 2017年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
4
主要终点
Participants' comprehension of the FuRST 2.0 rating scale measured by qualitative analysis

研究概览

简要总结

The FuRST 2.0 scale is being developed as a Patient Reported Outcome (PRO) with information coming directly from the Huntington's Disease Gene Expansion Carrier (HDGEC) and companion through self-report. The purpose of this study is to identify real or potential comprehension or usage problems with questionnaire items or response options. Through a process of structured cognitive de-briefing with HDGEC participants and companions, independently, followed by qualitative analysis, the final phrasing of the individual items and response options for the scale will be generated. Depending on the results of the first round of cognitive pre-testing, additional rounds of cognitive pre-testing may be required.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Participants' comprehension of the FuRST 2.0 rating scale measured by qualitative analysis

时间窗: 8 months

The primary assessment will use qualitative analysis of the cognitive interview to determine the usability of the FuRST 2.0 scale in the HD population.

次要结局

  • The difference between the ratings of the HDGEC participants and the companions measured by the FuRST 2.0 rating scale(8 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

FuRST 2.0 Cognitive Pre-Testing | 临床试验